SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 14, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $304K total
Actionable Insight • Neutral

The CEO's option exercise and sale is a standard cashless exercise pattern, not a bearish signal. The EVP's sale is also routine for a $10B+ biotech. Monitor next earnings for aflatamet (CK-586) pipeline updates, but this insider activity provides no actionable trading signal.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$81.93
T+0 close · Jul 14, 2026 · via day close
Latest settled
−25.40%
T+60 · $61.12
Vs SPY
−28.78%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 14 $81.93entry
  2. T+1 · 4mo ago +0.84%α +0.45% · $82.62
  3. T+5 · 4mo ago −3.44%α −2.15% · $79.11
  4. T+20 · 3mo ago −6.69%α −9.18% · $76.45
  5. T+60 · 6w ago −25.40%α −28.78% · $61.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cytokinetics CEO Robert Blum exercised and sold 7,490 shares for ~$614K on July 13, and EVP R&D Fady Malik sold 3,500 shares for ~$303K on July 7. The CEO's sale follows a derivative exercise at $10.60, representing a large realized gain. The total cluster value of ~$917K is ~0.009% of the $10.2B market cap, trivial relative to company size. These are routine liquidity-driven sales, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$917.0K
Insiders
2

Key Facts

  • CEO Blum exercised 7,490 options at $10.60/share and immediately sold the shares at $82.02, netting ~$614K in proceeds
  • EVP R&D Malik sold 3,500 shares at $86.62 for ~$303K on July 7
  • Total cluster value of ~$917K represents ~0.009% of CYTK's $10.2B market cap
  • Both sales are open-market transactions; no 10b5-1 plan indicated
  • Cytokinetics has strong analyst consensus (89% bullish) with 25 buy-equivalent ratings

Financial Impact

Total insider sales of ~$917K, less than 0.01% of market cap, immaterial

dilution

Risk Factors

  • Insider sales could increase if additional option exercises occur near expiration
  • No 10b5-1 plan disclosed, future sales may be unpredictable

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1784057701171

Track record

46 reports on CYTK

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  4. Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  5. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  6. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
  9. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $53.17 −16.40% settles Dec 3
  10. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
Showing 10 of 46

US Market Status

Market Closed · Opens Wed (11h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 14, 2026